InvestLog
DNLI logo

DNLI

Denali Therapeutics Inc.NASDAQHealthcare
$20.65+4.93%ClosedMarket Cap: $3.27B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

4

Sales

2

Buy/Sell Ratio

2.00

Total Bought

$0.00

Total Sold

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Jan 08Watts Ryan J.director, officer: President and CEOSell35,198$16.50296,833
Thu Jan 08Schuth Alexander O.officer: COFO and SecretarySell17,218$16.50282,828
Mon Jan 05Schuth Alexander O.officer: COFO and SecretarySell57,700$0.00300,046
Mon Jan 05Schuth Alexander O.officer: COFO and SecretarySell173,100$16.27173,100
Mon Jan 05Watts Ryan J.director, officer: President and CEOSell78,960$0.00332,031
Mon Jan 05Watts Ryan J.director, officer: President and CEOSell236,880$16.27236,880
Mon Dec 15BAKER BROS. ADVISORS LPdirectorBuy2,095,191$0.0125,996,310
Mon Dec 15BAKER BROS. ADVISORS LPdirectorBuy190,523$0.012,335,469
Thu Nov 06Van Hauwermeiren TimothydirectorSell31,897$14.9231,897
Thu Nov 06Van Hauwermeiren TimothydirectorSell10,632$0.0010,632